Gray Susannah
- SEC CIK
- 0001833453
No open-market purchases or sales filed in the past year.
Current role at each company
- TBPHTheravance Biopharma, Inc.Directoras of Sep 24, 2026
- FDMT4D Molecular Therapeutics, Inc.Directoras of Jun 18, 2026
- MRVIMaravai Lifesciences Holdings, Inc.Directoras of May 28, 2026
- ANABAnaptysbio, IncDirectoras of Apr 29, 2026
- MORFMorphic Holding, Inc.Directoras of Aug 20, 2024
Show 1 more company
- APRApria, Inc.Directoras of Mar 29, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gray Susannah as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
No insider trades match these filters.